![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Tomsitz, Dirk 
ORCID: https://orcid.org/0000-0003-0036-072X; Livingstone, Elisabeth; Loquai, Carmen; Kaatz, Martin; Leiter, Ulrike ORCID: https://orcid.org/0000-0002-8019-1577; Schilling, Bastian ORCID: https://orcid.org/0000-0001-8859-4103; Terheyden, Patrick; Hassel, Jessica; Sachse, Michael; Ulrich, Jens; Dippel, Edgar; Meiss, Frank; Pföhler, Claudia; Kreuter, Alexander; Herbst, Rudolf; Weichenthal, Michael; Zimmer, Lisa; Meier, Friedegund; Rauschenberg, Ricarda; Mohr, Peter; Brunnert, Fiona; von Wasielewski, Imke; Gutzmer, Ralf; Schadendorf, Dirk ORCID: https://orcid.org/0000-0003-3524-7858; Berking, Carola ORCID: https://orcid.org/0000-0003-0229-8931; Ugurel, Selma und Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643
(22. März 2025):
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma.
In: Journal of the European Academy of Dermatology and Venereology, Bd. 39, Nr. 11: S. 1975-1986
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-0036-072X; Livingstone, Elisabeth; Loquai, Carmen; Kaatz, Martin; Leiter, Ulrike ORCID: https://orcid.org/0000-0002-8019-1577; Schilling, Bastian ORCID: https://orcid.org/0000-0001-8859-4103; Terheyden, Patrick; Hassel, Jessica; Sachse, Michael; Ulrich, Jens; Dippel, Edgar; Meiss, Frank; Pföhler, Claudia; Kreuter, Alexander; Herbst, Rudolf; Weichenthal, Michael; Zimmer, Lisa; Meier, Friedegund; Rauschenberg, Ricarda; Mohr, Peter; Brunnert, Fiona; von Wasielewski, Imke; Gutzmer, Ralf; Schadendorf, Dirk ORCID: https://orcid.org/0000-0003-3524-7858; Berking, Carola ORCID: https://orcid.org/0000-0003-0229-8931; Ugurel, Selma und Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643
(22. März 2025):
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma.
In: Journal of the European Academy of Dermatology and Venereology, Bd. 39, Nr. 11: S. 1975-1986
[PDF, 1MB]
DeTemple, Viola K. ORCID: https://orcid.org/0000-0001-6246-8862; Kaatz, Martin ORCID: https://orcid.org/0000-0002-0650-2576; Stockfleth, Eggert; Scheel, Christina; Angela, Yenny ORCID: https://orcid.org/0000-0002-6643-7286; Gutzmer, Ralf ORCID: https://orcid.org/0000-0001-7921-2820; Leiter, Ulrike; Meier, Friedegund ORCID: https://orcid.org/0000-0003-4340-9706; Schadendorf, Dirk ORCID: https://orcid.org/0000-0003-3524-7858; Livingstone, Elisabeth ORCID: https://orcid.org/0000-0001-8279-9239; Gebhardt, Christoffer ORCID: https://orcid.org/0000-0001-7090-9584; Wasielewski, Imke von; Weichenthal, Michael ORCID: https://orcid.org/0000-0002-9060-4961; Mohr, Peter; Hassel, Jessica ORCID: https://orcid.org/0000-0001-7575-6230; Pföhler, Claudia ORCID: https://orcid.org/0000-0003-0384-114X; Simon, Jan Christoph; Jochims, Franziska ORCID: https://orcid.org/0000-0003-2279-2072; Terheyden, Patrick; Ulrich, Jens; Haferkamp, Sebastian; Drexler, Konstantin; Schilling, Bastian; Glutsch, Valerie ORCID: https://orcid.org/0000-0001-9291-1327; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643; Berking, Carola; Ugurel, Selma ORCID: https://orcid.org/0000-0002-9384-6704 und Tomsitz, Dirk ORCID: https://orcid.org/0000-0003-0036-072X
(2025):
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma.
In: European Journal of Cancer, Bd. 225, 115590
[PDF, 2MB]
ORCID: https://orcid.org/0000-0001-6246-8862; Kaatz, Martin ORCID: https://orcid.org/0000-0002-0650-2576; Stockfleth, Eggert; Scheel, Christina; Angela, Yenny ORCID: https://orcid.org/0000-0002-6643-7286; Gutzmer, Ralf ORCID: https://orcid.org/0000-0001-7921-2820; Leiter, Ulrike; Meier, Friedegund ORCID: https://orcid.org/0000-0003-4340-9706; Schadendorf, Dirk ORCID: https://orcid.org/0000-0003-3524-7858; Livingstone, Elisabeth ORCID: https://orcid.org/0000-0001-8279-9239; Gebhardt, Christoffer ORCID: https://orcid.org/0000-0001-7090-9584; Wasielewski, Imke von; Weichenthal, Michael ORCID: https://orcid.org/0000-0002-9060-4961; Mohr, Peter; Hassel, Jessica ORCID: https://orcid.org/0000-0001-7575-6230; Pföhler, Claudia ORCID: https://orcid.org/0000-0003-0384-114X; Simon, Jan Christoph; Jochims, Franziska ORCID: https://orcid.org/0000-0003-2279-2072; Terheyden, Patrick; Ulrich, Jens; Haferkamp, Sebastian; Drexler, Konstantin; Schilling, Bastian; Glutsch, Valerie ORCID: https://orcid.org/0000-0001-9291-1327; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643; Berking, Carola; Ugurel, Selma ORCID: https://orcid.org/0000-0002-9384-6704 und Tomsitz, Dirk ORCID: https://orcid.org/0000-0003-0036-072X
(2025):
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma.
In: European Journal of Cancer, Bd. 225, 115590
[PDF, 2MB]
Franklin, Cindy ORCID: https://orcid.org/0000-0001-9142-5423; Mohr, Peter; Bluhm, Leonie; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael ORCID: https://orcid.org/0000-0002-9060-4961; Pfoehler, Claudia; Herbst, Rudolf; Terheyden, Patrick ORCID: https://orcid.org/0000-0002-5894-1677; Utikal, Jochen; Ulrich, Jens; Debus, Dirk; Haferkamp, Sebastian; Kaatz, Martin; Forschner, Andrea ORCID: https://orcid.org/0000-0002-6185-4945; Leiter, Ulrike; Nashan, Dorothee; Kreuter, Alexander ORCID: https://orcid.org/0000-0003-2275-499X; Sachse, Michael; Welzel, Julia; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643; Meiss, Frank; Weishaupt, Carsten; Gambichler, Thilo ORCID: https://orcid.org/0000-0001-7862-3695; Weyandt, Gerhard; Dippel, Edgar; Schatton, Kerstin; Celik, Eren; Trommer, Maike ORCID: https://orcid.org/0000-0003-2864-4273; Helfrich, Iris; Roesch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, Susanne und Ugurel, Selma ORCID: https://orcid.org/0000-0002-9384-6704
(2022):
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, Nr. 6, e004509
ORCID: https://orcid.org/0000-0001-9142-5423; Mohr, Peter; Bluhm, Leonie; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael ORCID: https://orcid.org/0000-0002-9060-4961; Pfoehler, Claudia; Herbst, Rudolf; Terheyden, Patrick ORCID: https://orcid.org/0000-0002-5894-1677; Utikal, Jochen; Ulrich, Jens; Debus, Dirk; Haferkamp, Sebastian; Kaatz, Martin; Forschner, Andrea ORCID: https://orcid.org/0000-0002-6185-4945; Leiter, Ulrike; Nashan, Dorothee; Kreuter, Alexander ORCID: https://orcid.org/0000-0003-2275-499X; Sachse, Michael; Welzel, Julia; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643; Meiss, Frank; Weishaupt, Carsten; Gambichler, Thilo ORCID: https://orcid.org/0000-0001-7862-3695; Weyandt, Gerhard; Dippel, Edgar; Schatton, Kerstin; Celik, Eren; Trommer, Maike ORCID: https://orcid.org/0000-0003-2864-4273; Helfrich, Iris; Roesch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, Susanne und Ugurel, Selma ORCID: https://orcid.org/0000-0002-9384-6704
(2022):
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, Nr. 6, e004509
Kaehler, Katharina C.; Gutzmer, Ralf; Meier, Friedegrund; Zimmer, Lisa; Heppt, Markus; Gesierich, Anja; Thoms, Kai-Martin; Utikal, Jochen; Hassel, Jessica C.; Loquai, Carmen; Pfoehler, Claudia; Heinzerling, Lucie; Kaatz, Martin; Goeppner, Daniela; Pflugfelder, Annette; Bohne, Ann-Sophie; Satzger, Imke; Reinhardt, Lydia; Placke, Jan-Malte; Schadendorf, Dirk und Ugurel, Selma
(24. Mai 2021):
Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study.
In: Frontiers in Oncology, Bd. 11, 672172
[PDF, 5MB]
Knispel, Sarah; Stang, Andreas; Zimmer, Lisa; Lax, Hildegard; Gutzmer, Ralf; Heinzerling, Lucie; Weishaupt, Carsten; Pfoehler, Claudia; Gesierich, Anja; Herbst, Rudolf; Kaehler, Katharina C.; Weide, Benjamin; Berking, Carola; Loquai, Carmen; Utikal, Jochen; Terheyden, Patrick; Kaatz, Martin; Schlaak, Max; Kreuter, Alexander; Ulrich, Jens; Mohr, Peter; Dippel, Edgar; Livingstone, Elisabeth; Becker, Jürgen C.; Weichenthal, Michael; Chorti, Eleftheria; Gronewold, Janine; Schadendorf, Dirk und Ugurel, Selma
(2020):
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG.
In: Journal for Immunotherapy of Cancer, Bd. 8, Nr. 1, e000395
Leiter, Ulrike; Stadler, Rudolf; Mauch, Cornelia; Hohenberger, Werner; Brockmeyer, Norbert H.; Berking, Carola; Sunderkoetter, Cord; Kaatz, Martin; Schatton, Kerstin; Lehmann, Percy; Vogt, Thomas; Ulrich, Jens; Herbst, Rudolf; Gehring, Wolfgang; Simon, Jan-Christoph; Keim, Ulrike; Verver, Danielle; Martus, Peter und Garbe, Claus
(2019):
Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.
In: Journal of Clinical Oncology, Bd. 37, Nr. 32
Ugurel, Selma; Loquai, Carmen; Terheyden, Patrick; Schadendorf, Dirk; Richtig, Erika; Utikal, Jochen; Gutzmer, Ralf; Rass, Knuth; Sunderkötter, Cord; Stein, Annette; Fluck, Michäl; Kaatz, Martin; Trefzer, Uwe; Kähler, Katharina; Stadler, Rudolf; Berking, Carola; Höller, Christoph; Kerschke, Laura; Edler, Lutz; Kopp-Schneider, Annette und Becker, Jürgen C.
(2017):
Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial.
In: Oncotarget, Bd. 8, Nr. 44: S. 76029-76043
Leiter, Ulrike; Stadler, Rudolf; Mauch, Cornelia; Hohenberger, Werner; Brockmeyer, Norbert; Berking, Carola; Sunderkötter, Cord; Kaatz, Martin; Schulte, Klaus-Werner; Lehmann, Percy; Vogt, Thomas; Ulrich, Jens; Herbst, Rudolf; Gehring, Wolfgang; Simon, Jan-Christoph; Keim, Ulrike; Martus, Peter und Garbe, Claus
(2016):
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
In: Lancet Oncology, Bd. 17, Nr. 6: S. 757-767